Vision CHC
ActiveSummary
The computed 12-month bankruptcy probability of Vision CHC is 2.3% (moderate). The 2025 annual accounts show equity of €238.2m and a net result of -€9,085. Equity is growing by about 4.1% per year across the filed financial years. The company has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals.
Group and network
Holdings and subsidiaries
1 holding · 11 subsidiaries in the treeHoldings 1
-
100%
All subsidiaries, including indirect ones 11
Companies in which this company or one of its subsidiaries holds more than half, or which it consolidates according to the LEI register.
Vision Consumer Health 100%10 subsidiaries
VISION HEALTHCARE 100%9 subsidiaries
- AixSwiss BVNL 100%
- Bärbel Drexel GmbHDE 100%
- Flinndal BVNL 100%
- New Care Supplements BVNL 100%
- Nordic Nutriment ApSDK 100%
- PURASANA 100%
- Remark BVNL 100%
- VISION HEALTHCARE B.V.NL 100%
- Vision Healthcare Nordic ABSE 100%
According to the 2025 annual accounts of Vision CHC and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Connections & network
The network starts from this company’s shareholders. What else they own or run appears here as nodes.